Antipyretic TRIZ Cases
- NEP Inhibitor Treatment for Equine Laminitis
Neural endopeptidase inhibitor stabilizes hoof structures and improves blood flow, resolving treatment complexity in equine laminitis.
- Bifidobacterium Cell Extracts Modulate Monocytes for Infection Treatment
Probiotic cell extracts from Bifidobacterium animalis modulate monocyte subpopulations to deliver immunostimulating effects.
- Adhesive Cooling Sheet Moisture Management
Fiber sheet absorbs moisture from hydrous polymer gel to enable sustained evaporation, resolving insufficient absorption in humid environments.
- Humanized IL-17A Antibodies Resolving Immunogenicity
Humanizing rodent CDRs on human frameworks reduces immunogenicity while preserving therapeutic efficacy for inflammatory disorders.
- Adipose Stem Cell Composition for IL-17 Inhibition
Adipose tissue-derived mesenchymal stem cells suppress interleukin-17 production, offering a safer alternative to steroid therapies with fewer side effects.
- Microneedle Arrays for Lymphatic Delivery via Permeability Enhancement
Reversible permeability enhancers increase epidermal porosity to facilitate bioactive agent uptake by lymphatic capillaries.
- Anti-Activin A Antibodies Inhibit Cachexia Muscle Loss
Isolated antigen binding proteins inhibit activin A activity by blocking its receptor binding, thereby preventing cachexia-induced muscle and fat mass loss.
- TDO Vaccine Compositions Targeting Immune Evasion in Cancer
Vaccines using TDO peptides elicit cytotoxic T-cell responses that overcome immune tolerance driven by enzyme-mediated tryptophan depletion.
- ROCK2 Inhibitor Systemic Administration via Selective Binding
Formula I compound inhibits ROCK2 with high selectivity, enabling systemic administration for diseases mediated by Rho-associated protein kinase.
- Fc Variant Amino Acid Modifications Reduce Effector Functions
Specific amino acid deletions in the Fc region lower C1q and Fc gamma receptor binding, minimizing unwanted ADCC and CDC side effects.